[1]赵丽娟,公晓红.抗精神病药物引发的体重增加与HTR2C基因-759C/T 多态性关联的Meta分析[J].医学信息,2019,32(13):56-62.[doi:10.3969/j.issn.1006-1959.2019.13.017]
　ZHAO Li-juan,GONG Xiao-hong.Meta-analysis of the Association between Weight Gain Induced by Antipsychotic Drugs and HTR2C Gene-759C/T Polymorphism[J].Journal of Medical Information,2019,32(13):56-62.[doi:10.3969/j.issn.1006-1959.2019.13.017]
点击复制

抗精神病药物引发的体重增加与HTR2C基因-759C/T 多态性关联的Meta分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年13期
页码:
56-62
栏目:
论著
出版日期:
2019-07-01

文章信息/Info

Title:
Meta-analysis of the Association between Weight Gain Induced by Antipsychotic Drugs and HTR2C Gene-759C/T Polymorphism
文章编号:
1006-1959（2019）13-0056-07
作者:
赵丽娟1; 2; 公晓红1
1.复旦大学生命科学学院遗传工程国家重点实验室，上海 200438； 2.上海交通大学医学院附属精神卫生中心，上海 201108
Author(s):
ZHAO Li-juan1; 2; GONG Xiao-hong1
1.State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai 200438,China; 2.Affiliated Mental Health Center,School of Medicine,Shanghai Jiaotong University,Shanghai 201108,China
关键词:
HTR2C-759C/T; 精神分裂症; 抗精神病药; BMI; 体重增加
Keywords:
Key words：HTR2C-759C/T; Schizophrenia; Antipsychotic drugs; BMI; Weight gain
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2019.13.017
文献标志码:
A
摘要:
目的 探讨抗精神病药物在治疗精神分裂症患者过程中出现的体重增加与5羟色胺2C受体（HTR2C）基因启动子区-759C/ T（rs3813929）单核苷酸多态性的关系。方法 在Pubmed、 Springer、China biology medicine disc（CBM）、谷歌学术、万方数据库等检索1990~2017年精神分裂症患者中有关HTR2C-759C/T 基因多态性与抗精神病药物诱导的体重增加关联性研究的文献，对-759C/T 位点（CT+TT）/CC，（CT+CC）/TT基因型进行Meta分析。用RevMan version 5.3计算OR值及95%可信区间，并按人种因素作亚组分析。结果 共有20篇文献符合纳入标准，经Meta分析发现HTR2C-759T与抗精神病药物引发的体重增加呈显著负相关[（CT+TT）/ CC OR=0.42，95%CI（0.26~0.66），P=0.0002]。亚组分析中，高加索人群和东亚人群含HTR2C-759T患者的体重增加占比人数显著低于CC基因型患者（高加索人群OR=0.48，95%CI（0.26~0.88），P=0.020，东亚人群OR=0.34，95%CI（0.17~0.69），P=0.002）。HTR2C-759C 与抗精神病药物引发的体重增加有正相关趋势[（CT+CC）/TT OR=2.29，95% CI（1.00~5.23），P=0.05]。亚组分析中高加索人群[OR=2.58，95% CI（0.61~10.94），P=0.200]和东亚人群（OR=2.13，95%CI（0.78~5.86），P=0.14）结论一致，差异无统计学意义（P＞0.05）。结论 HTR2C 基因启动子-759C/T单核苷酸多态性与抗精神病药物导致的患者体重增加相关联，携带HTR2C-759T可能是限制体重增加的保护因子。
Abstract:
Abstract：Objective To investigate the relationship between the weight gain of antipsychotic drugs in the treatment of schizophrenia patients and the single nucleotide polymorphism of the serotonin 2C receptor (HTR2C) gene promoter region-759C/T (rs3813929). Methods Search for HTR2C-759C/T gene polymorphisms associated with antipsychotic-induced weight gain in patients with schizophrenia from 1990 to 2017 in Pubmed, Springer, China biology medicine disc (CBM), Google Scholar, and Wanfang database. For the sex study, a meta-analysis was performed on the -759C/T locus (CT+TT)/CC, (CT+CC)/TT genotype. The OR value and the 95% confidence interval were calculated using RevMan version 5.3 and subgroup analysis was performed by ethnographic factors. Results A total of 20 articles met the inclusion criteria. Meta-analysis found that HTR2C-759T was significantly negatively correlated with weight gain induced by antipsychotic drugs [(CT+TT)/CC OR=0.42, 95%CI(0.26-0.66),P=0.0002]. In the subgroup analysis, the proportion of weight gain in the Caucasian and East Asian populations with HTR2C-759T was significantly lower than that in the CC genotype (Caucasian population OR=0.48,95%CI(0.26-0.88), P=0.020, East Asian population) OR=0.34,95%CI(0.17~0.69),P=0.002). HTR2C-759C had a positive correlation with weight gain induced by antipsychotic drugs [(CT+CC)/TT OR=2.29,95%CI(1.00~5.23),P=0.05].In the subgroup analysis, the Caucasian population [OR=2.58, 95%CI (0.61~10.94), P=0.200] and the East Asian population (OR=2.13,95%CI(0.78~5.86), P=0.14) were consistent,the difference was not statistically significant (P>0.05). Conclusion The HTR2C gene promoter-759C/T single nucleotide polymorphism is associated with weight gain in patients with antipsychotic drugs, and carrying HTR2C-759T may be a protective factor limiting weight gain.

参考文献/References:

[1]Lord CC,Wyler SC,Wan R,et al.The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C[J].J Clin Invest,2017,127(9):3402-3409. [2]Zhang JP,Lencz T,Zhang RX,et al.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain:A SystematicReview and Meta-analysis[J].Schizophr Bull,2016,42(6):1418-1437. [3]Ma X,Maimaitirexiati T,Zhang R,et al.HTR2C polymorphisms,olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients:A meta-analysis[J]. International Journal of Psychiatry in Clinical Practice,2014,18(4):229-242. [4]Ellingrod VL,Perry PJ,Ringold JC,et al.Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine[J].Am J Med Genet B Neuropsychiatr Genet,2005, 134B(1):76-78. [5]Kuzman MR,Medved V,Bozina N,et al.The influence of 5-HT(2C)and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients[J].Psychiatry Res,2008,160(3):308-315. [6]Park YM,Cho JH,Kang SG,et al.Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients[J].J Clin Pharm Ther,2008,33(1):55-60. [7]Godlewska BR,Olajossy-Hilkesberger L,Ciwoniuk M,et al.Olanzapine-induced weight gain is associated with the 759C/T and 697G/C polymorphisms of the HTR2C gene[J].Pharmacogenomics J,2009,9(4):234-241. [8]Kanga SH,Leea JI,Hanb HR,et al.Polymorphisms of the leptin and HTR2C genes and clozapine-induced weight change and baseline BMI in patients with chronic schizophrenia[J]. Psychiatric Genetics,2014,24(6):249-256. [9]Gr?觍dinaru RC,Andreescu NI,Nussbaum LA,et al.-759C/T polymorphism of the HTR2C gene is not correlated with atypical antipsychotics-induced weight gain,among Romanian psychotic patients[J].Rom J Morphol Embryol,2016,57(4):1343-1349. [10]刘伟忠,何红波,何震宇,等.奥氮平致体质量增加与HTR2C 受体基因-759C/T多态性的关联研究[J].医药导报,2013,32(6):733-737. [11]邵平,赵靖平,陈晋东,等.5-羟色胺2C受体基因-759C/T和-697G/C多态性与抗精神病药物所致体质量增加的关联[J].中南大学学报(医学版),2008,33(4):312-315. [12]Reynolds GP,Zhang ZJ,Zhang XB.Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism[J].Lancet,2002,359(9323):2086-2087. [13]Basile VS,Masellis M,Luca VD,et al.-759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain[J].Lancet,2002,360(9347):1790-1791. [14]Theisen FM,Hinneya A, Br?觟mel T,et al.Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals[J].Psychiatric Genetics,2004,14(3):139-142. [15]Templeman LA,Reynolds GP,Arranz B,et al.Polymorphisms of the 5-HT2C receptor and leptin genes areassociated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis[J].Pharmacogenetics and Genomics,2005,15(4):195-200. [16]Miller DD,Ellingrod VL,Holman TL,et al.Clozapine-Induced Weight Gain Associated With the 5HT2C Receptor 759C/T Polymorphism[J].American Journal of Medical Genetics Part B (Neuropsychiatric Genetics),2005,133B(1):97-100. [17]Ryu R,Cho EY,Park T,et al.-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment[J].Progress in Neuro-Psychopharmacology& Biological Psychiatry,2007,31(3):673-677. [18]Bak M,Fransen A,Janssen J,et al.Almost All Antipsychotics Result in Weight Gain:A Meta-Analysis[J].PLoS One,2014,9(4):e94112. [19]Lord CC,Wyler SC,Wan R,et al.The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C[J].J Clin Invest,2017,127(9):3402-3406.

相似文献/References:

[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
　ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Journal of Medical Information,2018,31(13):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
　ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Journal of Medical Information,2018,31(13):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(13):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
　CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(13):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
　SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(13):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[6]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
　SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Journal of Medical Information,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[7]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
　WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(13):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[8]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
　SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Journal of Medical Information,2018,31(13):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[9]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
　LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Journal of Medical Information,2018,31(13):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[10]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
　HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Journal of Medical Information,2018,31(13):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]

更新日期/Last Update: 2019-07-01